PMID,Title,Journal,Year
40569464,Potential anticancer effects of sodium-glucose cotransporter protein 2 (SGLT2) inhibitors Canagliflozin and Dapagliflozin.,Cancer chemotherapy and pharmacology,2025
40336737,Intravesical fungus ball following robot-assisted radical prostatectomy in diabetes mellitus patient.,IJU case reports,2025
38826603,Effects of Switching From Another Sodium-Glucose Cotransporter 2 Inhibitor to Tofogliflozin on Nocturia in Patients With Type 2 Diabetes.,Cureus,2024
38416196,Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations.,Naunyn-Schmiedeberg's archives of pharmacology,2024
37684337,The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy.,Communications biology,2023
32704566,The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews.,"Endocrinology, diabetes & metabolism",2020
32522924,"Severe Visceral Obesity, Fatty Liver and Diabetes after Orchiectomy for Prostate Cancer.","Internal medicine (Tokyo, Japan)",2020
32089542,A Case of Fournier's Gangrene in a Patient Taking Canagliflozin for the Treatment of Type II Diabetes Mellitus.,The American journal of case reports,2020
27689018,The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration.,Molecular metabolism,2016
